Skip to Main Content

Paper Details

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Ann Oncol
220
2021
COVID-, COVID-19, Cancer, DNA methyltransferase, PATIENTS, Patients, SARS-CoV, SARS-CoV-2, anticancer, cancer, cardiovascular and pulmonary comorbidities, coronavirus, coronavirus 2019, creatinine, diabetes mellitus, etoposide, hematologic malignancy, hematological malignancy, lactate, lactate dehydrogenase, lymphocyte, neutrophil, obesity, patients, platelet, platinum, renal disease, severe acute respiratory syndrome coronavirus 2, troponin
Author NameAffiliation
Toni K ChoueiriDana-Farber Cancer Institute
Donna R RiveraNational Cancer Institute
Eric B DurbinMarkey Cancer Center, University of Kentucky
Eric B DurbinMarkey Cancer Center, University of Kentucky
Matthew D GalskyTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Philip E LammersBaptist Cancer Center
Rachel P RosovskyMassachusetts General Hospital, Harvard Medical School
Peter Paul Yu
Jeremy L WarnerVanderbilt University Medical Center
  • 1 - 9

Datasets

Release 1.2